We would love to hear your thoughts about our site and services, please take our survey here.
Yes it’s hard to sound optimistic at the moment I hope the board manage to find someone decent to partner with and move the company forward but when the last set of results showed that we were beginning to come close to potentially making a profit I thought it would have been all steam ahead in securing more contracts.
I understand the share price did not reflect fair value but surely a bod should be the first people to know that the SP is temporary and if you keep producing good rns and figures the market will follow.
Just going to keep crossing my fingers for now and keep the faith it’s a brilliant company who always seem to be on the right track was always going to be ups and downs. Ai in clinical trials is getting mentioned allover these days it’s use will become adopted in more and more places so hopefully an investment bank will be interested in getting a foothold in a growth area.
Unfortunately looking at the 3rd rns you can see that was in fact peel hunt selling 630k in 2 trades 2300 and 627700. Not a good sign really hope they have got a hold of this situation and didn’t make the MVP comment in order to drum up support as it doesn’t seem to be working currently.
Insain@tunnelvision
It’s all very odd. Peel hunt have brought 2599 at 96p and sold 1300 at 99p to make a whopping £39. I haven’t got a clue what’s going on there.
Just a very strange situation at the moment hard to judge what is going on. All I know is if an institution wants to take a large stake in sensyne its very cheap for them currently. I don’t really get why they are messing about with thousands.
I thought this looked set for north of 300, anyone shed any light on reason for the pullback over the past few days.
It’s unmissable at 35p there will be a boost in instructions in January as there always is. Lockdown has thrown the traditional calendar out but next year the standard listing rush in January will resume.
So more land to mine, can anyone who’s been here since 2019 explain the rationale for the purchase? I assume it is in a good location that has been proven to be n the past or have we been allowed to do exploration? Hopefully we are getting a good deal
It is mad to look through all these disclosures and see the big hitters such as bailie Gifford and hsbc.
They are not going to settle for a poor deal I just don’t see it happening.
I don’t see how it can’t be at least double that considering the progress the company has made since ipo and the value added to the assets. I suppose Drayson is thinking the same thing when he looks at the share price. Unfortunately aim scares off a lot of investors and I think that’s been a problem for us
I know the form 8 and 8.3 are to do with takeover code. Companies have to disclose their existing holdings and dealings when a potential offer has been made.
I’m 100% that hsbc have brought that stake. But the invesco 4.6% I’m not sure whether they are just disclosing an existing holding…
Hsbc tr1 they have brought 5% of sensyne
invesco have brought 4.something% if I’m reading it right?
Could be time to fasten seatbelts
Cheers bluebelly I knew I’d seen something about it, hopefully we will get an ipo date sometime soon.
Great news, not a license just yet but for anyone looking at a jv or offtake we are now more attractive with 100% ownership. Well done BOD
I think the problem is even if it is going on the likelihood of securing a prosecution is low because these people aren’t stupid and won’t leave tracks or evidence.
This rounds up the legislation simply
https://www.stpaulschambers.com/what-is-insider-dealing/
Call me an optimist, but could we be in the quiet period after listing on nasdaq. Just been through the Argo ipo and they weren’t allowed to release news for 30 or 45 days can’t remember exactly but maybe this is what’s going on atm.
Shear class what makes you think an offer wouldn’t be made for all our shares? I highly doubt that our board alone has the capital available to take us private and keep the company running. This would suggest either a pharma company or investment bank hedge fund etc would partner with the existing board, I can’t imagine they would want existing private shareholders to be involved and therefore would make an offer to buy us out. That’s my limited knowledge though.
How do you think we could end up in a situation where we end up with shares in a non listed company?
I think we can all guess who it was quite easily after today’s rns lol
I can see why he would consider taking the company private at this level we are far too cheap everyone knows it. The question is have management been pulling strings to lower the price to a level they are comfortable an offer will be accepted.
It has always struck me with sensyne that there is always a significant price move before good or bad news, this hasn’t bothered me too much in the past because I was always holding for good news and brought more at placings. Ultimately we will find out whether the board want shareholders do receive fair value when the offer comes in.
The fact is we have a very desirable dataset which would interest many companies so there is potential for multiple offers if the board are getting us out there properly.
I hope that this is all done with good intentions however I’ve got a feeling this could be a way in which the board will buy sensyne at a cheap value in partnership with an investor and then relist in America in the future. That is a total guess mind due and I hope to see a takeover offer in £3-£5 area which I think would be realistic.
Late reported trades from 29th Oct totalling 4million quids worth. Someone is confident
Has anyone been today 2 o clock Voco Thames hotel in Oxford?